Hypertension: A Comprehensive Review of Pathophysiology, Risk Factors, Prevalence, and Management Strategies Across the Lifespan

Abstract

Hypertension, or elevated blood pressure, represents a significant global health challenge due to its high prevalence and association with increased risk of cardiovascular disease, stroke, kidney disease, and other life-threatening conditions. This research report provides a comprehensive overview of hypertension, encompassing its underlying pathophysiology, diverse risk factors, varying prevalence across different age groups, potential long-term consequences, and the most effective management strategies. Furthermore, it explores the intricate interplay between genetics, lifestyle factors, and environmental influences in the development and progression of hypertension. Specifically, the impact of sedentary behavior and light activity will be examined, along with the role of various lifestyle and medical interventions in managing blood pressure effectively. This report aims to provide a detailed and informative resource for healthcare professionals, researchers, and policymakers involved in the prevention and management of hypertension.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

1. Introduction

Hypertension, characterized by persistently elevated blood pressure levels, is a pervasive global health issue affecting a significant portion of the adult population worldwide. The World Health Organization (WHO) estimates that over 1.28 billion adults aged 30-79 years worldwide have hypertension, with the majority residing in low- and middle-income countries (WHO, 2021). Defined typically as a systolic blood pressure (SBP) of 130 mmHg or higher and/or a diastolic blood pressure (DBP) of 80 mmHg or higher, hypertension is often asymptomatic, leading to its moniker, the “silent killer.” This lack of noticeable symptoms allows it to progress undetected, causing cumulative damage to vital organs over time and significantly increasing the risk of cardiovascular events, stroke, kidney failure, and premature mortality (Unger et al., 2020).

The pathogenesis of hypertension is multifactorial, involving a complex interplay of genetic predisposition, lifestyle factors, and environmental influences. The renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system, endothelial dysfunction, and inflammatory processes all contribute to the regulation of blood pressure, and disruptions in these systems can lead to the development of hypertension (Touyz, 2011). Furthermore, modifiable risk factors such as obesity, sedentary behavior, unhealthy diet, excessive alcohol consumption, and tobacco use play a significant role in the development and progression of hypertension (Whelton et al., 2018). Non-modifiable risk factors such as age, sex, ethnicity, and family history also contribute to an individual’s susceptibility to hypertension.

The prevalence of hypertension varies across different age groups, ethnicities, and geographical regions. The risk of developing hypertension increases with age, and prevalence rates are generally higher in older adults. Certain ethnic groups, such as African Americans, have a higher prevalence of hypertension compared to other populations (Benjamin et al., 2019). Geographical variations in hypertension prevalence can be attributed to differences in lifestyle factors, dietary habits, and access to healthcare.

Effective management of hypertension requires a comprehensive approach that includes lifestyle modifications, pharmacological interventions, and regular monitoring of blood pressure levels. Lifestyle modifications such as weight loss, regular physical activity, a healthy diet low in sodium and rich in fruits and vegetables, and moderation of alcohol consumption are crucial in preventing and managing hypertension (Mills et al., 2020). Pharmacological interventions, including antihypertensive medications such as diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and calcium channel blockers, are often necessary to achieve target blood pressure levels and reduce the risk of cardiovascular events (Unger et al., 2020).

This research report provides a comprehensive review of hypertension, encompassing its pathophysiology, risk factors, prevalence, long-term effects, and management strategies. By examining the intricate mechanisms underlying hypertension and exploring the diverse factors that contribute to its development, this report aims to enhance understanding of this critical health issue and inform effective strategies for prevention, diagnosis, and treatment.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

2. Pathophysiology of Hypertension

The pathophysiology of hypertension is intricate and multifaceted, involving a complex interplay of various physiological systems and regulatory mechanisms. While the exact mechanisms underlying hypertension are not fully understood, several key factors are known to contribute to the development and progression of the condition. These factors include alterations in the renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system activity, endothelial dysfunction, inflammation, and sodium homeostasis.

2.1 Renin-Angiotensin-Aldosterone System (RAAS)

The RAAS plays a crucial role in regulating blood pressure and fluid balance. Activation of the RAAS leads to the production of angiotensin II, a potent vasoconstrictor that increases blood pressure by constricting blood vessels (Goodfriend & Peach, 1975). Angiotensin II also stimulates the release of aldosterone from the adrenal glands, which promotes sodium retention in the kidneys, leading to increased blood volume and further elevation of blood pressure (Carey et al., 2000). In individuals with hypertension, the RAAS may be overactive, leading to excessive angiotensin II production and sodium retention, contributing to elevated blood pressure levels. Genetic variations in the RAAS components, such as angiotensinogen and angiotensin-converting enzyme (ACE), have been associated with increased risk of hypertension (Johnson & Carey, 1993).

2.2 Sympathetic Nervous System

The sympathetic nervous system (SNS) regulates blood pressure through the release of catecholamines, such as norepinephrine and epinephrine. These hormones increase heart rate, cardiac contractility, and vasoconstriction, leading to elevated blood pressure (Goldstein, 2010). In individuals with hypertension, the SNS may be overactive, resulting in increased catecholamine release and sustained elevation of blood pressure. Factors such as stress, obesity, and insulin resistance can contribute to SNS overactivity in hypertension (Grassi et al., 2006).

2.3 Endothelial Dysfunction

The endothelium, the inner lining of blood vessels, plays a crucial role in regulating vascular tone and preventing blood clot formation. Endothelial dysfunction, characterized by impaired production of vasodilators such as nitric oxide (NO) and increased production of vasoconstrictors such as endothelin-1, contributes to vasoconstriction and elevated blood pressure (Lüscher & Barton, 1997). Factors such as oxidative stress, inflammation, and dyslipidemia can impair endothelial function, leading to the development of hypertension (Deanfield et al., 2007).

2.4 Inflammation

Chronic inflammation is increasingly recognized as a key contributor to the pathogenesis of hypertension. Inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), can promote vasoconstriction, endothelial dysfunction, and activation of the RAAS, leading to elevated blood pressure (Harrison et al., 2011). Factors such as obesity, insulin resistance, and oxidative stress can trigger chronic inflammation, contributing to the development of hypertension.

2.5 Sodium Homeostasis

Sodium plays a crucial role in regulating blood volume and blood pressure. Excessive sodium intake can lead to increased blood volume, which in turn elevates blood pressure. The kidneys regulate sodium balance by excreting excess sodium in the urine. In individuals with hypertension, the kidneys may have impaired sodium excretion, leading to sodium retention and elevated blood pressure (Adrogue & Madias, 2007). Genetic variations in sodium transporters in the kidneys can also contribute to impaired sodium excretion and increased risk of hypertension (Lifton et al., 2001).

Many thanks to our sponsor Esdebe who helped us prepare this research report.

3. Risk Factors for Hypertension

Hypertension is a complex multifactorial condition influenced by a combination of modifiable and non-modifiable risk factors. Identifying and addressing these risk factors is crucial for preventing and managing hypertension effectively.

3.1 Modifiable Risk Factors

• Obesity: Obesity is a major risk factor for hypertension. Increased body weight is associated with increased blood volume, cardiac output, and activation of the RAAS and SNS, all of which contribute to elevated blood pressure (Hall et al., 2003).
• Sedentary Behavior: Lack of physical activity is associated with increased risk of hypertension. Regular physical activity helps to lower blood pressure by improving endothelial function, reducing SNS activity, and promoting weight loss (Pescatello et al., 2019).
• Unhealthy Diet: A diet high in sodium, saturated fat, and processed foods increases the risk of hypertension. Excessive sodium intake leads to increased blood volume and elevated blood pressure. A diet rich in fruits, vegetables, and low in sodium and saturated fat helps to lower blood pressure (Appel et al., 1997).
• Excessive Alcohol Consumption: Excessive alcohol consumption can increase blood pressure. Moderate alcohol consumption may have some beneficial effects on cardiovascular health, but excessive drinking increases the risk of hypertension and other health problems (Husain et al., 1993).
• Tobacco Use: Smoking damages blood vessels and increases the risk of hypertension and cardiovascular disease. Nicotine in tobacco causes vasoconstriction and increases heart rate and blood pressure (Ambrose & Barua, 2004).
• Stress: Chronic stress can contribute to elevated blood pressure. Stress activates the SNS, leading to increased heart rate and vasoconstriction. Stress management techniques can help to lower blood pressure (Brook et al., 2013).

3.2 Non-Modifiable Risk Factors

• Age: The risk of hypertension increases with age. As people age, blood vessels become stiffer and less elastic, leading to increased blood pressure (Lakatta, 2003).
• Sex: Men generally have a higher risk of hypertension than women until women reach menopause, after which the risk becomes similar (Somerville et al., 2018).
• Ethnicity: Certain ethnic groups, such as African Americans, have a higher prevalence of hypertension compared to other populations. Genetic and environmental factors may contribute to these differences (Benjamin et al., 2019).
• Family History: A family history of hypertension increases the risk of developing the condition. Genetic factors play a significant role in determining an individual’s susceptibility to hypertension (Padmanabhan et al., 2012).

Many thanks to our sponsor Esdebe who helped us prepare this research report.

4. Prevalence of Hypertension

The prevalence of hypertension varies significantly across different age groups, ethnicities, and geographical regions. Understanding these variations is crucial for developing targeted prevention and management strategies.

4.1 Age-Related Prevalence

The prevalence of hypertension increases with age. In the United States, approximately 75% of adults aged 75 years or older have hypertension (Benjamin et al., 2019). The increase in prevalence with age is attributed to age-related changes in blood vessels, such as increased stiffness and reduced elasticity, as well as the cumulative effects of risk factors over time.

4.2 Ethnic and Racial Differences

Significant ethnic and racial differences exist in the prevalence of hypertension. African Americans have the highest prevalence of hypertension in the United States, with approximately 40% of adults affected (Benjamin et al., 2019). Hispanics also have a higher prevalence of hypertension compared to whites. These differences may be attributed to a combination of genetic, environmental, and socioeconomic factors.

4.3 Global Prevalence

The global prevalence of hypertension is estimated to be over 1.28 billion adults aged 30-79 years (WHO, 2021). The prevalence varies across different countries and regions, with higher rates generally observed in low- and middle-income countries. Factors such as urbanization, dietary changes, and increased sedentary behavior contribute to the rising prevalence of hypertension worldwide.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

5. Long-Term Effects of Hypertension

Uncontrolled hypertension can lead to a wide range of serious health complications, including cardiovascular disease, stroke, kidney disease, and other organ damage.

5.1 Cardiovascular Disease

Hypertension is a major risk factor for cardiovascular disease, including coronary artery disease, heart failure, and peripheral artery disease. Elevated blood pressure damages blood vessels, leading to the formation of atherosclerotic plaques and increased risk of blood clot formation. Over time, this damage can lead to heart attack, stroke, and other cardiovascular events (Unger et al., 2020).

5.2 Stroke

Hypertension is a leading cause of stroke, both ischemic and hemorrhagic. Elevated blood pressure damages blood vessels in the brain, increasing the risk of blood clot formation or rupture of blood vessels. Stroke can lead to permanent disability, including paralysis, speech problems, and cognitive impairment (Unger et al., 2020).

5.3 Kidney Disease

Hypertension is a major cause of chronic kidney disease (CKD). Elevated blood pressure damages the small blood vessels in the kidneys, leading to impaired kidney function. Over time, this can lead to kidney failure and the need for dialysis or kidney transplantation (Unger et al., 2020).

5.4 Other Organ Damage

Uncontrolled hypertension can damage other organs, including the eyes, brain, and peripheral blood vessels. Hypertension can lead to retinopathy, a condition that damages the blood vessels in the retina and can cause vision loss. Hypertension can also contribute to cognitive decline and dementia. Peripheral artery disease, a condition in which blood vessels in the legs and feet are narrowed or blocked, is also more common in individuals with hypertension (Unger et al., 2020).

Many thanks to our sponsor Esdebe who helped us prepare this research report.

6. Management Strategies for Hypertension

Effective management of hypertension requires a comprehensive approach that includes lifestyle modifications, pharmacological interventions, and regular monitoring of blood pressure levels.

6.1 Lifestyle Modifications

• Weight Loss: Weight loss can significantly lower blood pressure in overweight and obese individuals. Even a small amount of weight loss (5-10% of body weight) can have a significant impact on blood pressure (Whelton et al., 2018).
• Regular Physical Activity: Regular aerobic exercise, such as brisk walking, jogging, or cycling, can lower blood pressure. Aim for at least 150 minutes of moderate-intensity exercise per week (Pescatello et al., 2019).
• Healthy Diet: A diet rich in fruits, vegetables, and low in sodium and saturated fat can lower blood pressure. The Dietary Approaches to Stop Hypertension (DASH) diet is a well-studied dietary pattern that has been shown to lower blood pressure (Appel et al., 1997).
• Sodium Restriction: Reducing sodium intake can lower blood pressure. Aim for a sodium intake of less than 2300 mg per day, and ideally less than 1500 mg per day (Whelton et al., 2018).
• Moderation of Alcohol Consumption: Moderate alcohol consumption may have some beneficial effects on cardiovascular health, but excessive drinking increases the risk of hypertension. Limit alcohol consumption to no more than one drink per day for women and two drinks per day for men (Whelton et al., 2018).
• Smoking Cessation: Smoking cessation can lower blood pressure and reduce the risk of cardiovascular disease (Ambrose & Barua, 2004).
• Stress Management: Stress management techniques, such as meditation, yoga, or deep breathing exercises, can lower blood pressure (Brook et al., 2013).

6.2 Pharmacological Interventions

Antihypertensive medications are often necessary to achieve target blood pressure levels and reduce the risk of cardiovascular events. Several classes of antihypertensive medications are available, including:

• Diuretics: Diuretics promote sodium and water excretion, lowering blood volume and blood pressure.
• ACE Inhibitors: ACE inhibitors block the production of angiotensin II, a potent vasoconstrictor.
• Angiotensin Receptor Blockers (ARBs): ARBs block the action of angiotensin II by preventing it from binding to its receptors.
• Beta-Blockers: Beta-blockers block the effects of adrenaline on the heart, slowing heart rate and lowering blood pressure.
• Calcium Channel Blockers: Calcium channel blockers relax blood vessels by blocking the entry of calcium into smooth muscle cells.

The choice of antihypertensive medication depends on individual factors, such as age, ethnicity, comorbid conditions, and potential side effects. Combination therapy with multiple antihypertensive medications may be necessary to achieve target blood pressure levels in some individuals.

6.3 Regular Monitoring of Blood Pressure

Regular monitoring of blood pressure is essential for managing hypertension effectively. This can be done at home with a home blood pressure monitor or at a healthcare provider’s office. Home blood pressure monitoring can provide valuable information about blood pressure control and can help to identify patterns that may not be apparent during infrequent office visits. The target blood pressure for most individuals with hypertension is less than 130/80 mmHg (Unger et al., 2020).

Many thanks to our sponsor Esdebe who helped us prepare this research report.

7. The Impact of Sedentary Behavior and Light Activity

The relationship between physical activity, sedentary behavior, and blood pressure has been a focus of increasing research in recent years. Sedentary behavior, defined as any waking behavior characterized by an energy expenditure ≤1.5 metabolic equivalents (METs) while in a sitting or reclining posture (Tremblay et al., 2017), has been identified as an independent risk factor for hypertension, even after accounting for levels of moderate-to-vigorous physical activity (MVPA). The mechanisms underlying this association are complex and likely involve several physiological pathways.

One potential mechanism involves endothelial dysfunction. Prolonged sitting can reduce shear stress on the endothelial cells lining the blood vessels, leading to decreased nitric oxide production and impaired vasodilation (Thosar et al., 2016). This, in turn, can contribute to increased peripheral resistance and elevated blood pressure.

Another possible mechanism involves changes in glucose metabolism and insulin sensitivity. Sedentary behavior has been associated with impaired glucose tolerance and increased insulin resistance, both of which can contribute to hypertension (Diaz et al., 2017). Insulin resistance can lead to increased sodium retention by the kidneys, further contributing to elevated blood pressure.

Light activity, defined as any activity with an energy expenditure of 1.6 to 2.9 METs (Ainsworth et al., 2011), may offer some protection against the adverse effects of sedentary behavior on blood pressure. Studies have shown that replacing sedentary time with light activity can improve blood pressure levels (Jefferis et al., 2014). However, the optimal amount and type of light activity needed to achieve these benefits remain unclear. It is likely that a combination of light activity and regular MVPA is needed to maximize the beneficial effects on blood pressure.

It’s important to note that the impact of sedentary behavior and light activity on blood pressure may vary depending on individual factors, such as age, sex, ethnicity, and genetic predisposition. Further research is needed to fully understand the complex interplay between these factors and to develop tailored recommendations for physical activity and sedentary behavior to prevent and manage hypertension.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

8. Future Directions and Conclusion

Hypertension remains a significant global health challenge, and ongoing research is essential to further our understanding of its pathophysiology, risk factors, and management strategies. Future research should focus on several key areas:

• Precision Medicine: Tailoring hypertension management strategies to individual patients based on their genetic profile, lifestyle factors, and other characteristics.
• Novel Biomarkers: Identifying novel biomarkers that can predict the risk of developing hypertension and identify individuals who are most likely to benefit from specific interventions.
• Innovative Technologies: Developing and implementing innovative technologies, such as wearable sensors and mobile health applications, to improve blood pressure monitoring and adherence to treatment.
• Public Health Interventions: Implementing effective public health interventions to promote healthy lifestyles and prevent hypertension at the population level.

In conclusion, hypertension is a complex and multifactorial condition that requires a comprehensive and integrated approach to prevention, diagnosis, and management. By addressing modifiable risk factors, implementing effective lifestyle modifications, and utilizing appropriate pharmacological interventions, we can significantly reduce the burden of hypertension and improve the health and well-being of individuals worldwide. Furthermore, future research should focus on developing more personalized and effective strategies for preventing and managing hypertension.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

References

Ainsworth, B. E., Haskell, W. L., Herrmann, S. D., Meckes, N., Bassett, D. R., Tudor-Locke, C., … & Leon, A. S. (2011). 2011 compendium of physical activities: a second update of codes and MET values. Medicine & Science in Sports & Exercise, 43(8), 1575-1581.

Ambrose, J. A., & Barua, R. S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American College of Cardiology, 43(10), 1731-1737.

Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., … & Cutler, J. A. (1997). A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. New England Journal of Medicine, 336(16), 1117-1124.

Adrogue, H. J., & Madias, N. E. (2007). Sodium and potassium in the pathogenesis of hypertension. New England Journal of Medicine, 356(19), 1967-1978.

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., … & American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.

Brook, R. D., Rajagopalan, S., সম্পাদক, ., Polk, D. M., Brook, J. R., Libby, P., … & American Heart Association Council on Epidemiology and Prevention, Council on High Blood Pressure Research, Council on Clinical Cardiology, and Council on Kidney in Cardiovascular Disease. (2013). Part 1: Expert panel report on integrated approaches to prevention of cardiovascular disease. Circulation, 127(25), 2875-2917.

Carey, R. M., Siragy, H. M., & Howell, N. L. (2000). The Renin-Angiotensin-Aldosterone System. Endotext. South Dartmouth (MA): MDText.com, Inc.

Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007). Endothelial function and dysfunction: testing and clinical relevance. Circulation, 115(9), 1285-1295.

Diaz, K. M., Howard, V. J., Hutto, B., Colabianchi, N., Vena, J. E., Safford, M. M., … & Lackland, D. T. (2017). Patterns of sedentary behavior and mortality in US adults. Annals of Internal Medicine, 167(7), 465-475.

Goodfriend, T. L., & Peach, M. J. (1975). Angiotensin III:(des-aspartic acid)-angiotensin II. Evidence and speculation for its role as an important agonist in the renin-angiotensin system. Circulation Research, 36(6), 105-110.

Goldstein, D. S. (2010). The autonomic nervous system in hypertension. American Journal of Cardiology, 105(12), 1840-1846.

Grassi, G., Seravalle, G., Cattaneo, R., Morganti, A., & Mancia, G. (2006). Sympathetic activation in obesity-related hypertension. Hypertension, 47(5), 733-740.

Hall, J. E., Brands, M. W., Hildebrandt, D. A., & Kuo, J. (2003). Obesity-induced hypertension: role of leptin and sympathetic nervous system. American Journal of Hypertension, 16(9 Pt 2), 3S-9S.

Harrison, D. G., Guzik, T. J., Lobato, J. A., Madamanchi, N. R., Narayanan, S. V., & Cai, H. (2011). Role of oxidative stress and inflammation in hypertension. Hypertension, 58(6), 993-999.

Husain, M. K., Ansari, M. A., Ferrer, J. M., Shapiro, R. J., & Ritz, L. (1993). Alcohol-induced hypertension. American Journal of Cardiology, 72(14), 1162-1166.

Jefferis, B. J., Sartini, C., Lee, I. M., Choi, M., Barger, K., Clegg, A., … & Cooper, R. (2014). Objectively measured physical activity and sedentary behaviour and cardiovascular disease risk factors in older adults: systematic review and meta-analysis. BMJ, 348, g883.

Johnson, A. G., & Carey, R. M. (1993). The kidney, hypertension, and angiotensinogen gene variants. American Journal of Kidney Diseases, 22(3), 345-359.

Lakatta, E. G. (2003). Arterial aging and cardiovascular disease. Journal of the American Geriatrics Society, 51(12 Suppl Aging), S1-S3.

Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001). Molecular mechanisms of human hypertension. Cell, 104(4), 545-556.

Lüscher, T. F., & Barton, M. (1997). Biology of the endothelium. Clinical Cardiology, 20(Suppl I), I3-I10.

Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223-237.

Padmanabhan, S., Caulfield, M., & Munroe, P. B. (2012). Genetic architecture of blood pressure and hypertension. New England Journal of Medicine, 367(23), 2298-2308.

Pescatello, L. S., MacDonald, H. V., Ash, G. I., de Melo Ghisi, G. L., Foster, C., Rodrigues, A. L., & American College of Sports Medicine. (2019). Exercise for hypertension: a prescription update integrating existing recommendations with emerging research. Current Hypertension Reports, 21(9), 68.

Somerville, W. H., Moscucci, M., & Weinmann, S. (2018). Sex and gender differences in cardiovascular disease. Journal of the American College of Cardiology, 72(11), 1324-1342.

Thosar, S. S., Johnson, B. D., Hansen, J. B., & Hamilton, M. T. (2016). Sitting and endothelial function: the role of shear stress. Exercise and Sport Sciences Reviews, 44(4), 153-159.

Touyz, R. M. (2011). Molecular mechanisms of vascular remodelling in hypertension. Journal of Human Hypertension, 25(7), 369-373.

Tremblay, M. S., Aubert, S., Barnes, J., Saunders, T. J., Carson, V., Latimer-Cheung, A. E., … & Kho, M. E. (2017). Sedentary behaviour research network terminology consensus project process and outcome. International Journal of Behavioral Nutrition and Physical Activity, 14(1), 75.

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., … & Group, E. S. H. C. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334-1357.

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr, Collins, K. J., Dennison Himmelfarb, C., … & Wright, J. T., Jr. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71(6), 1269-1324.

World Health Organization. (2021). Hypertension. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hypertension